Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6710118> ?p ?o }
Showing triples 1 to 48 of
48
with 100 triples per page.
- Q6710118 subject Q8282130.
- Q6710118 subject Q8375173.
- Q6710118 subject Q8732563.
- Q6710118 subject Q9010304.
- Q6710118 subject Q9245259.
- Q6710118 abstract "Lysergic acid 2,4-dimethylazetidide (LA-SS-Az, LSZ) is an analog of LSD developed by the team led by David E. Nichols at Purdue University. It was developed as a rigid analog of LSD with the diethylamide group constrained into an azetidine ring in order to map the binding site at the 5-HT2A receptor. There are three possible stereoisomers around the azetidine ring, with the (S,S)-(+) isomer being the most active, slightly more potent than LSD itself in drug discrimination tests using trained rats.There have been several unconfirmed reports of lysergic acid 2,4-dimethylazetidide being synthesized in illicit laboratories and distributed on blotter paper or in liquid solution under names such as "diazedine" and "λ".In 2013 LSZ also appeared on some designer drug and research chemical markets in the UK.REDIRECT Template:Unreliable source?This is a redirect from a page that has been moved (renamed). This page was kept as a redirect to avoid breaking links, both internal and external, that may have been made to the old page name. For more information follow the bold category link. LSZ later gained international popularity through a small cluster of mail-order novel psychedelic shops that appeared in 2012.↑ ↑ ↑ ↑ ↑ ↑".
- Q6710118 casNumber "470666-31-0".
- Q6710118 casSupplemental "(S,S) isomer, freebase".
- Q6710118 casSupplemental "470666-32-1 (S,S) isomer, tartrate salt".
- Q6710118 iupacName "(8β)-8-{[(2S,4S)-2,4-Dimethylazetidin-1-yl]carbonyl}-6-methyl-9,10-didehydroergoline".
- Q6710118 pubchem "10472143".
- Q6710118 thumbnail LSD-azetidine.svg?width=300.
- Q6710118 wikiPageExternalLink made.
- Q6710118 wikiPageWikiLink Q10897.
- Q6710118 wikiPageWikiLink Q14891424.
- Q6710118 wikiPageWikiLink Q1964398.
- Q6710118 wikiPageWikiLink Q19805.
- Q6710118 wikiPageWikiLink Q2066956.
- Q6710118 wikiPageWikiLink Q208467.
- Q6710118 wikiPageWikiLink Q21096201.
- Q6710118 wikiPageWikiLink Q214514.
- Q6710118 wikiPageWikiLink Q217741.
- Q6710118 wikiPageWikiLink Q23118.
- Q6710118 wikiPageWikiLink Q235816.
- Q6710118 wikiPageWikiLink Q3017818.
- Q6710118 wikiPageWikiLink Q425376.
- Q6710118 wikiPageWikiLink Q4652233.
- Q6710118 wikiPageWikiLink Q4686856.
- Q6710118 wikiPageWikiLink Q5324462.
- Q6710118 wikiPageWikiLink Q7120374.
- Q6710118 wikiPageWikiLink Q8282130.
- Q6710118 wikiPageWikiLink Q8375173.
- Q6710118 wikiPageWikiLink Q8732563.
- Q6710118 wikiPageWikiLink Q9010304.
- Q6710118 wikiPageWikiLink Q9245259.
- Q6710118 casNumber "470666".
- Q6710118 casSupplemental "470666".
- Q6710118 casSupplemental "isomer, freebase".
- Q6710118 iupacName "-8".
- Q6710118 pubchem "10472143".
- Q6710118 type ChemicalSubstance.
- Q6710118 type Drug.
- Q6710118 type ChemicalObject.
- Q6710118 type Thing.
- Q6710118 type Q8386.
- Q6710118 comment "Lysergic acid 2,4-dimethylazetidide (LA-SS-Az, LSZ) is an analog of LSD developed by the team led by David E. Nichols at Purdue University. It was developed as a rigid analog of LSD with the diethylamide group constrained into an azetidine ring in order to map the binding site at the 5-HT2A receptor.".
- Q6710118 label "Lysergic acid 2,4-dimethylazetidide".
- Q6710118 depiction LSD-azetidine.svg.